BECTON, DICKINSON AND COMPANY Operating Cash Flow
BECTON, DICKINSON AND COMPANY (BDX) reported Operating Cash Flow of $657.00 million for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-02-09
- BECTON, DICKINSON AND COMPANY net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $657.00M, a 5.19% decline year-over-year.
- BECTON, DICKINSON AND COMPANY net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was $693.00M.
- BECTON, DICKINSON AND COMPANY net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was $444.00M, a 62.63% decline year-over-year.
- BECTON, DICKINSON AND COMPANY net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was $674.00M, a 56.03% decline year-over-year.
- BECTON, DICKINSON AND COMPANY net cash provided by (used in) operating activities for fiscal 2021 was $4.65B, a 31.31% increase from fiscal 2020.
- BECTON, DICKINSON AND COMPANY net cash provided by (used in) operating activities for fiscal 2020 was $3.54B, a 6.28% increase from fiscal 2019.
- BECTON, DICKINSON AND COMPANY net cash provided by (used in) operating activities for fiscal 2019 was $3.33B, a 16.23% increase from fiscal 2018.
- BECTON, DICKINSON AND COMPANY net cash provided by (used in) operating activities for fiscal 2018 was $2.87B, a 12.35% increase from fiscal 2017.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $657.00M 10-Q · filed 2026-02-09 | |||
| 2024-12-31 | $693.00M 10-Q · filed 2026-02-09 | |||
| 2022-03-31 | $444.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05 | $1.12B 10-Q · filed 2022-05-05 | $2.07B derived: sum of 3 quarters · filed 2022-05-05 | $3.04B derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | $674.00M 10-Q · filed 2022-02-03 | $1.63B derived: sum of 2 quarters · filed 2022-02-03 | $2.60B derived: sum of 3 quarters · filed 2022-02-03 | $3.79B derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-09-30 | $951.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $1.93B derived: sum of 2 quarters · filed 2021-11-24 | $3.11B derived: sum of 3 quarters · filed 2022-05-05 | $4.65B 10-K · filed 2021-11-24 |
| 2021-06-30 | $975.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | $2.16B derived: sum of 2 quarters · filed 2022-05-05 | $3.70B 10-Q · filed 2021-08-05 | $5.18B derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-03-31 | $1.19B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05 | $2.72B 10-Q · filed 2022-05-05 | $4.20B derived: sum of 3 quarters · filed 2022-05-05 | $5.06B derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.53B 10-Q · filed 2022-02-03 | $3.01B derived: sum of 2 quarters · filed 2022-02-03 | $3.88B derived: sum of 3 quarters · filed 2022-02-03 | $4.36B derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | $1.48B derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $2.34B derived: sum of 2 quarters · filed 2021-11-24 | $2.83B derived: sum of 3 quarters · filed 2021-11-24 | $3.54B 10-K · filed 2021-11-24 |
| 2020-06-30 | $862.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | $1.34B derived: sum of 2 quarters · filed 2021-08-05 | $2.06B 10-Q · filed 2021-08-05 | $3.43B derived: sum of 4 quarters · filed 2021-11-24 |
| 2020-03-31 | $483.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-06 | $1.20B 10-Q · filed 2021-05-06 | $2.57B derived: sum of 3 quarters · filed 2021-11-24 | $3.50B derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-12-31 | $713.00M 10-Q · filed 2021-02-04 | $2.08B derived: sum of 2 quarters · filed 2021-11-24 | $3.02B derived: sum of 3 quarters · filed 2021-11-24 | $3.80B derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-09-30 | $1.37B derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $2.30B derived: sum of 2 quarters · filed 2021-11-24 | $3.08B derived: sum of 3 quarters · filed 2021-11-24 | $3.33B 10-K · filed 2021-11-24 |
| 2019-06-30 | $932.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | $1.71B derived: sum of 2 quarters · filed 2020-08-06 | $1.96B 10-Q · filed 2020-08-06 | $3.27B derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $782.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $1.03B 10-Q · filed 2020-05-07 | $2.33B derived: sum of 3 quarters · filed 2020-11-25 | $2.88B derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $245.00M 10-Q · filed 2020-02-06 | $1.55B derived: sum of 2 quarters · filed 2020-11-25 | $2.09B derived: sum of 3 quarters · filed 2020-11-25 | $2.79B derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | $1.31B derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $1.85B derived: sum of 2 quarters · filed 2020-11-25 | $2.54B derived: sum of 3 quarters · filed 2020-11-25 | $2.87B 10-K · filed 2020-11-25 |
| 2018-06-30 | $542.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-06 | $1.24B derived: sum of 2 quarters · filed 2019-08-06 | $1.56B 10-Q · filed 2019-08-06 | $2.69B derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | $697.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $1.02B 10-Q · filed 2019-05-09 | $2.14B derived: sum of 3 quarters · filed 2019-11-27 | $2.53B derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-12-31 | $320.00M 10-Q · filed 2019-02-05 | $1.45B derived: sum of 2 quarters · filed 2019-11-27 | $1.83B derived: sum of 3 quarters · filed 2019-11-27 | $2.56B derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-09-30 | $1.13B derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.51B derived: sum of 2 quarters · filed 2019-11-27 | $2.23B derived: sum of 3 quarters · filed 2019-11-27 | $2.55B 10-K · filed 2019-11-27 |
| 2017-06-30 | $384.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $1.11B derived: sum of 2 quarters · filed 2018-08-02 | $1.42B 10-Q · filed 2018-08-02 | $2.13B derived: sum of 4 quarters · filed 2018-11-21 |
| 2017-03-31 | $725.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-03 | $1.04B 10-Q · filed 2018-05-03 | $1.75B derived: sum of 3 quarters · filed 2018-11-21 | $2.58B derived: sum of 4 quarters · filed 2018-11-21 |
| 2016-12-31 | $315.00M 10-Q · filed 2018-02-06 | $1.02B derived: sum of 2 quarters · filed 2018-11-21 | $1.85B derived: sum of 3 quarters · filed 2018-11-21 | $2.41B derived: sum of 4 quarters · filed 2018-11-21 |
| 2016-09-30 | $705.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21 | $1.54B derived: sum of 2 quarters · filed 2018-11-21 | $2.10B derived: sum of 3 quarters · filed 2018-11-21 | $2.56B 10-K · filed 2018-11-21 |
| 2016-06-30 | $834.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $1.39B derived: sum of 2 quarters · filed 2017-08-03 | $1.85B 10-Q · filed 2017-08-03 | $2.53B derived: sum of 4 quarters · filed 2017-11-22 |
| 2016-03-31 | $557.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-02 | $1.02B 10-Q · filed 2017-05-02 | $1.70B derived: sum of 3 quarters · filed 2017-11-22 | $2.24B derived: sum of 4 quarters · filed 2017-11-22 |
| 2015-12-31 | $463.00M 10-Q · filed 2017-02-02 | $1.14B derived: sum of 2 quarters · filed 2017-11-22 | $1.68B derived: sum of 3 quarters · filed 2017-11-22 | |
| 2015-09-30 | $678.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | $1.22B derived: sum of 2 quarters · filed 2017-11-22 | $1.73B 10-K · filed 2017-11-22 | |
| 2015-06-30 | $538.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-04 | $1.05B 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $514.00M 10-Q · filed 2016-05-06 | |||
| 2014-09-30 | $1.75B 10-K · filed 2016-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |